NRG1 and Alzheimer disease: While other studies suggest that NRG1 signaling at other sites could have beneficial roles in AD (Ryu et al., 2016; Xu et al., 2016; Ou et al., 2021), here we show that specifically targeting NRG1 signaling on CNS microglia can slow or stop neuroinflammation and neurodegeneration in AD animals.